(Q45020866)

8 December 2017

title

In-vitro susceptibility of E. coli, Shigellae and Salmonellae to kanamycin and therapeutic implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5336392

3 May 2023

0 references

1 reference

history and philosophy of science

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1966.TB43025.X

3 May 2023

author name string

J. D. Nelson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5336392

3 May 2023

K. C. Haltalin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5336392

3 May 2023

language of work or name

English

0 references

publication date

1 June 1966

1 reference

full work available at URL

8 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1749-6632.1966.tb43025.x

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1966.TB43025.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1749-6632.1966.tb43025.x/fullpdf

3 May 2023

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1966.TB43025.X

Annals of the New York Academy of Sciences

3 May 2023

published in

1 reference

8 December 2017

volume

132

1 reference

8 December 2017

issue

2

1 reference

8 December 2017

page(s)

1006-1012

1 reference

Susceptibility and crossresistance of bacteria to four related antibiotics: kanamycin, paromomycin, neomycin and streptomycin

8 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1966.TB43025.X

3 May 2023

Q78683528

3

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1966.TB43025.X

Kanamycin for bowel sterilization

3 May 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1966.TB43025.X

Clinical evaluation of the new antibiotic: kanamycin

3 May 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1966.TB43025.X

Kanamycin: experience in selected cases

3 May 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1966.TB43025.X

Some experiences with kanamycin in the treatment of Salmonella and Shigella infections.

3 May 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1966.TB43025.X

Kanamycin in anthrax, typhoid paratyphoid, and brucellosis

3 May 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1966.TB43025.X

3 May 2023

14

37

552

Geraci J. E.

1962

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1966.TB43025.X

IN VITRO SUSCEPTIBILITY OF SHIGELLAE TO SODIUM SULFADIAZINE AND TO EIGHT ANTIBIOTICS

3 May 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1966.TB43025.X

COLIFORM SEPTICEMIA COMPLICATING SHIGELLOSIS IN CHILDREN

3 May 2023

21

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1966.TB43025.X

EPITHELIAL CELL PENETRATION AS AN ESSENTIAL STEP IN THE PATHOGENESIS OF BACILLARY DYSENTERY.

3 May 2023

23

1 reference

https://api.crossref.org/works/10.1111/J.1749-6632.1966.TB43025.X

3 May 2023

Identifiers

1 reference

8 December 2017

1 reference